MED27 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 7.326800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
9.063200E-01
Normal-vs-Stage2
8.501800E-01
Normal-vs-Stage3
7.333000E-01
Normal-vs-Stage4
5.266600E-01
Stage1-vs-Stage2
9.407800E-01
Stage1-vs-Stage3
6.634200E-01
Stage1-vs-Stage4
5.963800E-01
Stage2-vs-Stage3
4.400000E-01
Stage2-vs-Stage4
4.777200E-01
Stage3-vs-Stage4
9.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
7.576200E-01
Normal-vs-AfricanAmerican
9.953800E-01
Normal-vs-Asian
2.594800E-01
Caucasian-vs-AfricanAmerican
6.665200E-01
Caucasian-vs-Asian
3.208200E-01
AfricanAmerican-vs-Asian
1.449840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
7.759800E-01
Normal-vs-Female
1.298980E-01
Male-vs-Female
4.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
8.347200E-01
Normal-vs-Age(41-60Yrs)
4.851600E-01
Normal-vs-Age(61-80Yrs)
8.800200E-01
Normal-vs-Age(81-100Yrs)
5.804400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.732000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.091000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.409000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.601800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.043200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
8.697200E-01
Normal-vs-Daily Drinker
5.009600E-01
Normal-vs-Weekly Drinker
4.761600E-01
Normal-vs-Occasional Drinker
2.078600E-01
Normal-vs-Social Drinker
1.949200E-01
Non Drinker-vs-Daily Drinker
9.853500E-02
Non Drinker-vs-Weekly Drinker
1.164420E-01
Non Drinker-vs-Occasional Drinker
1.624960E-01
Non Drinker-vs-Social Drinker
1.334640E-01
Daily Drinker-vs-Weekly Drinker
8.418200E-01
Daily Drinker-vs-Occasional Drinker
7.033600E-01
Daily Drinker-vs-Social Drinker
8.824000E-01
Weekly Drinker-vs-Occasional Drinker
8.367400E-01
Weekly Drinker-vs-Social Drinker
9.701400E-01
Occasional Drinker-vs-Social Drinker
8.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
9.940600E-01
Normal-vs-Grade 2
9.398000E-01
Normal-vs-Grade 3
8.981200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.835400E-01
Grade 1-vs-Grade 3
2.416800E-01
Grade 1-vs-Grade 4
9.940600E-01
Grade 2-vs-Grade 3
2.586600E-01
Grade 2-vs-Grade 4
9.398000E-01
Grade 3-vs-Grade 4
8.981200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
8.951200E-01
Normal-vs-NonDiabetic
6.219600E-01
Diabetic-vs-NonDiabetic
2.451600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
6.284200E-01
Normal-vs-NoPancreatitis
6.864800E-01
Pancreatitis-vs-NoPancreatitis
5.295200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
5.483800E-02
Normal-vs-N1
8.690200E-01
N0-vs-N1
8.825600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
3.352200E-01
Normal-vs-TP53-NonMutant
1.974600E-01
TP53-Mutant-vs-TP53-NonMutant
6.254600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap